Merck & Co Inc
XMUN:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
Pieris Pharmaceuticals Inc
F:PI6
|
US |
|
O
|
Orlen SA
PSE:PKN
|
PL |
|
S
|
Saputo Inc
F:SB7
|
CA |
|
G
|
General Mills Inc
DUS:GRM
|
US |
|
F
|
Fresenius SE & Co KGaA
XHAM:FRE
|
DE |
|
C
|
Conagra Brands Inc
DUS:CAO
|
US |
|
Banco de Sabadell SA
F:BDS
|
ES |
|
Y
|
Yoosung T&S Co Ltd
KOSDAQ:024800
|
KR |
|
US Foods Holding Corp
NYSE:USFD
|
US |
|
A
|
Ameren Corp
DUS:AE4
|
US |
|
C
|
Conagra Brands Inc
XMUN:CAO
|
US |
|
D
|
Danaher Corp
DUS:DAP
|
US |
|
A
|
Arrow Electronics Inc
F:ARW
|
US |
|
N
|
Nucor Corp
XMUN:NUO
|
US |
|
Mincon Group PLC
F:MIO
|
IE |
|
Alphamin Resources Corp
XTSX:AFM
|
MU |
|
V
|
Vertex Pharmaceuticals Inc
XHAM:VX1
|
US |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
|
C
|
China Coal Energy Co Ltd
XMUN:CVV
|
CN |
|
Equinor ASA
OSE:EQNR
|
NO |
|
Gaming and Leisure Properties Inc
NASDAQ:GLPI
|
US |
Bankruptcy Probability
Merck & Co Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merck & Co Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
466.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
356.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merck & Co Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merck & Co Inc has total debt of 51.1B USD. This includes both short-term (0 USD) and long-term (51.1B USD) debt.
You can find a full breakdown on its Balance Sheet.